As glioma-initiating stem cells are characterized by neural stem cell markers, e.g., nestin and CD133, downregulation of β-1,4-GalT-V was also accompanied by reduced mRNA expression of these neural stem cell markers, suggesting that CD133 and nestin may well have β-1-4 galactosylated epitope. This evidence concerns the gene PROM1 and central nervous system cancer.